Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Private equity firm Warburg Pincus and its affiliates have completed the acquisition of Bausch & Lomb for approximately $4.5 billion, including about $830 million of debt. Bausch & Lomb will cease to trade on the New York Stock Exchange and will be delisted.
Subscribe to our email newsletter
Ronald Zarrella, chairman and CEO of Bausch & Lomb, said: “With a strong and supportive partner in Warburg Pincus, we are well-positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry. Our customers will continue to receive high levels of service, product quality and innovation, and our commitment to serving their needs remains steadfast. On behalf of Bausch & Lomb’s management and board of directors, I want to thank our shareholders and hard-working employees for their support throughout this process.”
Elizabeth Weatherman, a Warburg Pincus managing director, said: “We are delighted to be partners with Bausch & Lomb, a global leader in vision care, ophthalmic devices and pharmaceuticals. We look forward to helping the company build upon its rich heritage and premier brand in ophthalmology.”